Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Accumulated Expenses (2016 - 2017)

Historic Accumulated Expenses for Tenax Therapeutics (TENX) over the last 6 years, with Q3 2017 value amounting to $223088.0.

  • Tenax Therapeutics' Accumulated Expenses fell 9334.9% to $223088.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $223088.0, marking a year-over-year decrease of 9334.9%. This contributed to the annual value of $5.2 million for FY2016, which is N/A changed from last year.
  • Latest data reveals that Tenax Therapeutics reported Accumulated Expenses of $223088.0 as of Q3 2017, which was down 9334.9% from $1.7 million recorded in Q2 2017.
  • Tenax Therapeutics' Accumulated Expenses' 5-year high stood at $5.2 million during Q4 2016, with a 5-year trough of $223088.0 in Q3 2017.
  • Moreover, its 4-year median value for Accumulated Expenses was $3.1 million (2015), whereas its average is $2.5 million.
  • In the last 5 years, Tenax Therapeutics' Accumulated Expenses soared by 6894.92% in 2016 and then tumbled by 9334.9% in 2017.
  • Quarter analysis of 4 years shows Tenax Therapeutics' Accumulated Expenses stood at $874876.0 in 2013, then surged by 254.89% to $3.1 million in 2015, then skyrocketed by 68.95% to $5.2 million in 2016, then plummeted by 95.75% to $223088.0 in 2017.
  • Its Accumulated Expenses was $223088.0 in Q3 2017, compared to $1.7 million in Q2 2017 and $3.6 million in Q1 2017.